SH2D1B Antikörper (AA 54-133)
Kurzübersicht für SH2D1B Antikörper (AA 54-133) (ABIN2359800)
Target
Alle SH2D1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - AA 54-133
 - 
                                            
Kreuzreaktivität
 - Human
 - 
                                            
Kreuzreaktivität (Details)
 - Calculated cross reactivity: Hu
 - 
                                            
Produktmerkmale
 - SH2D1B (SH2 Domain-containing Protein 1B, EWS/FLI1-activated Transcript 2, EAT-2, EAT2)
 - 
                                            
Aufreinigung
 - Purified by Protein A affinity chromatography.
 - 
                                            
Immunogen
 - Partial recombinant corresponding to aa54-133 from human SH2D1B (NP_444512) with GST tag. MW of the GST tag alone is 26kD.
 - 
                                            
Isotyp
 - IgG2a kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working conditions should be determined by the investigator.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - Supplied as a liquid in PBS, pH 7.2.
 - 
                                            
Lagerung
 - -20 °C
 - 
                                            
Informationen zur Lagerung
 - -20°C
 
 - 
                                            
 - 
    
- SH2D1B (SH2 Domain Containing 1B (SH2D1B))
 - 
                                            
Andere Bezeichnung
 - SH2D1B
 - 
                                            
NCBI Accession
 - NM_053282, NP_444512
 - 
                                            
Pathways
 - Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
 
Target
 -